EMT inhibitor-1
Names
[ CAS No. ]:
1638526-21-2
[ Name ]:
EMT inhibitor-1
Biological Activity
[Description]:
EMT inhibitor-1 is an inhibitor of of Hippo, TGF-β, and Wnt signaling pathways with antitumor activities.
[Related Catalog]:
[Target]
Hippo, TGF-β, Wnt[1].
[In Vitro]
EMT inhibitor-1 (C19) is an inhibitor of of Hippo, TGF-β, and Wnt signaling pathways with antitumor activities, inhibiting cancer cell migration, proliferation, and resistance to doxorubicin in vitro[1].
[In Vivo]
EMT inhibitor-1 (C19) exerts strong antitumor activity in a mouse tumor model. Mechanistically, EMT inhibitor-1 induces GSK3-β–mediated degradation of the Hippo transducer TAZ, through activation of the Hippo kinases Mst/Lats and the tumor suppressor kinase AMPK upstream of the degradation complex[1].
[References]
[Related Small Molecules]
XMU MP 1
|
ICG-001
|
SIS3
|
Salinomycin
|
Pirfenidone
|
IWR-1
|
Kartogenin
|
Wnt-C59
|
Berberine chloride hydrate
|
Pyrvinium pamoate
|
Disitertide
|
ETC-159
|
BML 284
|
IWP-2
Chemical & Physical Properties
[ Molecular Formula ]:
C12H12Cl2N2O2S
[ Molecular Weight ]:
319.21
[ Storage condition ]:
2-8℃